Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now
Corporate Profile

Investor Presentation

Read Now


Our Pipeline

Learn More
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

December 13, 2019

BeiGene Announces Clinical Data on Investigational Anti-PD-1 Antibody Tislelizumab in Combination with Sitravatinib at European Society for Medical Oncology Immuno-Oncology (ESMO I-O) Congress 2019

December 8, 2019

BeiGene Announces Clinical Data on BRUKINSA™ (Zanubrutinib) at the 61st American Society of Hematology (ASH) Annual Meeting

November 26, 2019

BeiGene to Present at the 31st Annual Piper Jaffray Healthcare Conference

Key Metrics

Key Metrics

  • 3,000


  • 1,000+

    Clinical team

  • 4


This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.